This Invention Relates to an Endoluminal Deployment System, a Stent Graft for endoluminal deployment and a method of endoluminal deployment of such a stent graft into a vessel with a side branch such as the thoracic arch of a patient.
The invention is particularly directed towards deploying a stent graft with a fenestration from which or into which a side arm can be deployed to enter one of the arteries that extends from the thoracic arch. These arteries are the innominate artery, the left carotid artery and the left subclavian artery. The invention will generally be discussed in relation to an endoluminal deployment system to enable branch grafting into the left subclavian artery but the invention may equally apply to the other arteries or to other vessels in the human or animal body.
Throughout this specification the term distal with respect to a portion of the aorta, a deployment device or a prosthesis is the end of the aorta, deployment device or prosthesis further away in the direction of blood flow away from the heart and the term proximal means the portion of the aorta, deployment device or end of the prosthesis nearer to the heart. When applied to other vessels similar terms such as caudal and cranial should be understood.
In one form therefore the invention is said to reside in a deployment system for a stent graft to be deployed into an internal lumen of a patient, the deployment system comprising an introducer with the stent graft retained thereon, the introducer having a proximal end intended to be deployed within a patient in use and a distal end intended to remain outside the patient and an auxiliary guide wire, the auxiliary guide wire extending to adjacent the proximal end of the introducer whereby the auxiliary guide wire can be extended from the proximal end of the introducer so that it can be snared from a side artery to assist with deployment of a stent graft into the side artery.
Preferably the introducer includes a sheath to retain the stent graft in a retracted state on the introducer.
The stent graft may be of a type which includes a side branch and the auxiliary guide wire extends through the side branch. Alternatively the stent graft can include a fenestration and the auxiliary guide wire extends through the fenestration. Alternatively the fenestration can include a graft tube extending into the stent graft from the fenestration either distally or proximally.
The auxiliary guide wire can be retained in an auxiliary catheter extending to the distal end of the introducer and the auxiliary guide wire can extend out between a nose cone on the proximal end of the introducer and a sheath on the introducer.
There may be provided a retention arrangement for the stent graft on the introducer which is adapted to retain the proximal and distal ends of the stent graft onto the introducer and includes trigger wires and trigger wire release mechanisms to release the proximal and distal retention arrangements.
Diameter reducing ties with an associated trigger wire and trigger wire release mechanisms can be used for the side arm stent graft, the diameter reducing ties being used to hold the diameter of the side arm reduced against the force of self expanding stents in the side arm so that it can be drawn into the side branch artery without unduly engaging the walls of the artery.
In a further form deployment device for deploying a branched stent graft in a thoracic arch of a patient, the stent graft being of a type having a main tubular body with a main lumen therethrough and a side arm with a side arm lumen extending therethrough, the deployment device including a main guide wire catheter extending from a proximal end to a distal end, a nose cone at the proximal end of the guide wire catheter an auxiliary guide wire catheter with an auxiliary guide wire extending therethrough extending from the distal end to the nose cone, the stent graft being retained on the main guide wire catheter distally of the nose cone with the main guide wire passing through the main lumen and the auxiliary guide wire extending through the main lumen and the side arm lumen and extending to the nose cone and the side branch being retained on the auxiliary guide wire catheter and a sheath coaxial with the main guide wire catheter and extending to the nose cone and enclosing the stent graft.
Preferably the stent graft and side arm on the stent graft include self-expanding stents and a tubular biocompatible graft.
In a further form the invention is said to reside in a deployment device for deploying a fenestrated stent graft in a thoracic arch of a patient, the stent graft being of a type having a main tubular body with a main lumen therethrough and a fenestration in the tubular body, the deployment device including a main guide wire catheter extending from a proximal end to a distal end, a nose cone at the proximal end of the guide wire catheter, an auxiliary catheter with an auxiliary guide wire extending therethrough extending from the distal end to the nose cone, the stent graft being retained on the main guide wire catheter distally of the nose cone with the main guide wire passing through the main lumen and the auxiliary catheter extending through the main lumen and the fenestration and further extending to the nose cone and a sheath coaxial with the main guide wire catheter and extending to the nose cone and enclosing the stent graft.
Preferably the stent graft is retained on the main guide wire catheter with the side arm extending proximally from its connection point with the main tubular body. Hence when advancing the side arm into the side branch artery the introducer with the stent graft retained on it is advanced proximally to allow the side arm to enter the side branch artery.
The stent graft and side arm on the stent graft may include self-expanding stents and a tubular biocompatible graft material covering the stents. The proximal stent may include barbs. There may also be provided at the distal end of the stent graft a distally extending uncovered self expanding stent with barbs to retain the distal end of the stent graft in the aorta. Alternatively the stent graft may be a proximal portion of a composite stent graft and the distal end of the stent graft can be adapted to be connected to or into another stent graft.
The stent graft may have a diameter of from 30 to 40 mm and a length of from 100 to 200 mm. The side arm may have a diameter of 10 to 15 mm and a length of from 20 to 50 mm. The self expanding stents in the main body of the graft and in the side arm may be Gianturco self expanding zigzag Z stents made from, for example, nitinol or stainless steel.
The deployment device may include a Y branch on the distal end thereof with the auxiliary guide wire catheter extending out of the Y branch. There can be provided a locking arrangement to fix the auxiliary guide wire with respect to the auxiliary guide wire catheter. Alternatively the auxiliary catheter can extend from the distal end of the handle.
In a further form the invention is said to reside in a method of introducing a fenestrated stent graft into the thoracic arch of a patient such that a stent graft can be deployed into the fenestration from the branch artery in the thoracic arch, the method including the steps of; (a) introducing an introducer via a femoral artery so that the fenestration is adjacent the branch artery to be grafted, (b) extending an auxiliary guide wire from the introducer, (c) snaring the auxiliary guide wire from the branch artery by means of a snare catheter introduced via a brachial artery and drawing the auxiliary guide wire into the brachial artery, (d) withdrawing the sheath from the introducer, (e) advancing a side arm stent graft on a side arm introducer over the auxiliary guide wire into the fenestration, (f) releasing the distal and proximal ends of the stent graft, and (g) releasing the side arm stent graft from the side arm introducer. In a further form the invention is said to reside in a method of introducing a branched stent graft into the thoracic arch of a patient such that the branch of the stent graft is deployed into the branch artery in the thoracic arch, the method including the steps of; (a) introducing an introducer via a femoral artery to adjacent the branch artery to be grafted, (b) extending an auxiliary guide wire from the introducer, (c) snaring the auxiliary guide wire from the branch artery by means of a snare catheter introduced via a brachial artery and drawing the auxiliary guide wire into the brachial artery, (d) inserting an artery wall protecting sleeve or catheter over the auxiliary guide wire via the brachial artery and clamping it to the auxiliary guide wire, (e) withdrawing the sheath from the introducer, (f) advancing the introducer proximally and drawing the side arm into the side branch artery using the artery wall protecting sleeve or catheter and the auxiliary guide wire, (g) releasing the distal and proximal ends of the stent graft, (h) releasing the diameter reducing ties on the side arm in the side branch artery, and (i) removing the introducer.
If necessary and depending upon the size of the aneurysm in the thoracic arch after deployment of the stent graft an extension stent graft may be deployed intra-luminally via the branch artery to connect into the side arm.
In the case of grafting into the left subclavian artery the branch artery into which the snare catheter can be introduced is the brachial artery in the left arm.
U.S. Pat. No. 5,387,235 entitled “Expandable Transluminal Graft Prosthesis For Repair Of Aneurysm” discloses apparatus and methods of retaining grafts onto deployment devices. These features and other features disclosed in U.S. Pat. No. 5,387,235 could be used with the present invention and the disclosure of U.S. Pat. No. 5,387,235 is herewith incorporated by reference in its entirety into this specification.
U.S. Pat. No. 5,720,776 entitled “Barb and Expandable Transluminal Graft Prosthesis For Repair of Aneurysm” discloses improved barbs with various forms of mechanical attachment to a stent. These features and other features disclosed in U.S. Pat. No. 5,720,776 could be used with the present invention and the disclosure of U.S. Pat. No. 5,720,776 is herewith incorporated by reference in its entirety into this specification.
PCT Patent Publication Number WO98/53761 entitled “A Prosthesis and a Method and Means of Deploying a Prosthesis” discloses an introducer for a prosthesis which retains the prosthesis so that each end can be moved independently. These features and other features disclosed in PCT Patent Publication Number No. WO98/53761 could be used with the present invention and the disclosure of PCT Patent Publication Number No. WO98/53761 is herewith incorporated by reference in its entirety into this specification.
PCT Patent Publication No. WO 03/034948 entitled “Prosthesis For Curved Lumens” discloses prostheses with arrangements for bending the prosthesis for placement into curved lumens. This feature and other features disclosed in PCT Patent Publication No. WO 03/034948 could be used with the present invention and the disclosure of PCT Patent Publication No. WO 03/034948 is herewith incorporated by reference in its entirety into this specification.
U.S. Pat. No. 6,206,931 entitled “Graft Prosthesis Materials” discloses graft prosthesis materials and a method for implanting, transplanting replacing and repairing a part of a patient and particularly the manufacture and use of a purified, collagen based matrix structure removed from a submucosa tissue source. These features and other features disclosed in U.S. Pat. No. 6,206,931 could be used with the present invention and the disclosure of U.S. Pat. No. 6,206,931 is herewith incorporated by reference in its entirety into this specification.
Australian Provisional Patent Application N PS3215 entitled “A Stent-Graft Fastening Arrangement”, and U.S. patent application Ser. No. 10/602,930, filed Jun. 24, 2003 entitled “Stent-Graft Fastening”, and PCT Patent Publication Number WO 2004/002365 disclose arrangements for fastening stents onto grafts particularly for exposed stents. This feature and other features disclosed in Australian Provisional Patent Application Number No. PS3215 and U.S. patent application Ser. No. 10/602,930, filed Jun. 24, 2003, and PCT Patent Publication Number WO 2004/002365 could be used with the present invention and the disclosure of Australian Provisional Patent Application Number PS3215 and U.S. patent application Ser. No. 10/602,930, filed Jun. 24, 2003, and PCT Patent Publication Number WO 2004/002365 are herewith incorporated by reference in their entirety into this specification.
Australian Provisional Application Number PR9617 entitled “Improving Graft Adhesion”, and U.S. Patent Application Publication No. US2003-0120332 and PCT Patent Publication Number No. WO03/053287 entitled “Stent Graft With Improved Adhesion” disclose arrangements on stent grafts for enhancing the adhesion of such stent grafts into walls of vessels in which they are deployed. This feature and other features disclosed in Australian Provisional Application Number PR9617, U.S. Patent Application Publication No. US2003-0120332, and PCT Patent Publication Number No. WO03/053287 could be used with the present invention and the disclosure of Australian Provisional Application Number PR9617, U.S. Patent Application Publication No. US2003-0120332, and PCT Patent Publication Number No. WO03/053287 are herewith incorporated by reference in their entirety into this specification.
This then generally describes the invention but to assist with understanding reference will now be made to the enclosed drawings which show a preferred embodiment of the device and the method of deploying the graft using the device.
In the drawings:
Now looking more closely at the drawings and in particular
It will be seen that the endoluminal deployment device generally comprises an introducer 1a comprising a deployment catheter 1 with a handle 2 at the distal end generally shown as 4. Covering a portion of the deployment catheter 1 is a sheath 3 extending proximally from a sheath manipulator 7.
At the proximal end 6 of the introducer 1a is a nose cone 8. The nose cone is fastened to the guide wire catheter 9 which extends from the distal end 4 of the introducer device to the nose cone. A guide wire 11 extends through the guide wire catheter 9. A pin vice 10 locks the guide wire catheter with respect to the deployment catheter 1 at the distal end 2a of the handle 2.
In the embodiment shown in
In the embodiment shown in
On the handle 2 is mounted a set of trigger wire release arrangements generally shown as 18 which will be discussed in detail later.
It will be noted that the nose cone 8 has, as particularly shown in
As can also be seen separately in various embodiments in
The stent graft 20 has a substantially tubular body with a lumen through it and with a proximal end 21 and a distal end 22. Four different embodiments of stent graft may be applicable to the present invention and these are shown in
As seen in
As can be seen in
The auxiliary catheter includes a bulge or “acorn” 44 where it passes through the side arm 23 with extra diameter reducing ties 46 either side of it. These diameter reducing ties 46 effectively grip the auxiliary guide wire catheter either side of the bulge or “acorn”. By this arrangement the auxiliary catheter cannot be moved with respect to the side arm unless the diameter reducing ties 46 are removed. This facilitates the moving of the side arm by preventing relative movement of the side arm with respect to the auxiliary catheter 12. The extra diameter reducing ties 46 can be released by the same trigger wire 31 that is used to release the diameter reducing ties 29.
Also on the side arm 23 are radio-opaque markers 33 which enable the position of the side arm to be observed by suitable radio-graphic techniques.
The proximal end 21 of the stent graft 20 is retained in a compressed condition and attached to the guide wire catheter 9 by a release arrangement 35 and a trigger wire 36 to release the release arrangement 35 is also present. Such a retention and release arrangement is depicted in PCT Publication WO 2004/017868 and the disclosure of this patent specification is incorporated by reference in its entirety herein and for all purposes.
A further trigger wire release arrangement (not shown in
It will be noted that the auxiliary catheter 13 and the auxiliary guide wire 14 pass through the lumen of the stent graft 20 as well as the lumen of the side arm 23 and then out through the notch 28 in the nose cone 8.
The trigger wire release arrangements 18 on the handle 2 includes three trigger wire release mechanisms. A first trigger wire release mechanism 40 is used to release the distal stent graft release mechanism via trigger wire 37, a second trigger wire release mechanism 41 is used to release the proximal end stent graft release mechanism 35 via trigger wire 36 and the third trigger wire release mechanism 42 is used to pull the trigger wire 31 which releases the diameter reducing ties 29. The trigger wire release mechanisms are operated in the order discussed as will be explained also later with respect to the various stages of deployment according to one embodiment of the invention. In some embodiments of the invention there may be only two trigger wire release mechanisms such as where the proximal and distal ends of the stent graft are retained by the same trigger wire.
Various embodiments of stent graft suitable for use with the present invention will now be discussed with reference to
Each of the stent grafts 20 has a tubular body of a biocompatible graft material and zig zag style Gianturco Z stents 24 along its length with a distally extending uncovered zig zag style Gianturco Z stent 26. It should be noted that in some embodiments of the stent graft for placement in the thoracic arch the distally extending uncovered zig zag style Gianturco Z stent 26 may not be present. This may be so, for instance, when the stent graft 20 is a proximal portion of a composite stent grafting system. The use of a composite stent grafting system is described in PCT publication WO 2004/017867, which claims priority to U.S. Provisional Patent Application No. 60/405,769 filed in the United States Patent Office on Aug. 23, 2002, which provisional application became U.S. application Ser. No. 10/645,095 filed in the United States Patent Office on Aug. 21, 2003, and which was published as United States Publication No. US 2004/0082990 which was published on Apr. 29, 2004, the disclosures of this patent specification is incorporated in its entirety herein and for all purposes.
The stents are inside the stent graft 20 at the proximal and distal ends 21, 22 and outside the stent graft 20 between the proximal end 21 and the distal end 22. The number of zig zag Gianturco Z stents along the length of the tubular graft 20 will depend upon the length of the stent graft 20. Normally the zig zag Gianturco Z stents are spaced apart to allow a degree of flexibility of the stent graft so that it can more easily fit the shape of a vessel into which it is deployed.
In each case the stent graft includes a fenestration but the treatment of the fenestration varies.
In
In
In an alternative arrangement the auxiliary catheter may have a zig zag configuration and pass up through the stent graft 20 and enter the graft material tube 87 at its end 89 and then exit through the fenestration 85.
In
In
The various stages of deployment of one embodiment of the stent graft 20 into the thoracic arch of a patient will now be discussed with reference to
The thoracic arch region of a patient generally comprises an ascending aorta 50 extending from an aortic valve 51 of the heart of the patient, then over the thoracic arch 52 to the descending aorta 53. From the thoracic arch three main arteries extend. These are the innominate artery 54, the left carotid artery 55 and a subclavian artery 56. This embodiment of the invention will generally be discussed with reference to deployment of a stent graft with a side branch into the aorta and left subclavian artery but the invention is not so restricted.
A stent graft may be necessary in the aortic arch region when an aneurysm 57 in the aorta extends up the aorta to such an extent that there is insufficient patent aortic wall to provide good sealing for a stent graft distally of the left subclavian artery 56. It is desirable in such circumstances to extend the stent graft to seal onto good artery wall at least between the left carotid artery 55 and the left subclavian artery 56.
The invention is not limited to this particular application but will be discussed in relation to this particular application.
As can be seen in
An incision can then be made into the brachial artery of the left arm and a snare catheter 60 introduced into the brachial artery and via that to the left subclavian artery and this snare catheter has a loop 61 at its end which can then be used to snare the guide wire 14. The snare is used to grip and pull the flexible guide wire 14 into the left subclavian artery and out through the brachial artery.
In the next stage shown in
As can be seen in
As can be seen in
As shown in
As shown in
Next as shown in
Finally as shown in
The auxiliary guide wire 14 can then be retracted into the introducer 1a and the introducer removed from the aorta to leave the stent graft 20 deployed in the aorta with the side arm 23 deployed into the left subclavian artery 56.
Throughout this specification various indications have been given as to the scope of this invention but the invention is not limited to any one of these but may reside in two or more of these combined together. The examples are given for illustration only and not for limitation.
Throughout this specification and the claims that follow unless the context requires otherwise, the words ‘comprise’ and ‘include’ and variations such as ‘comprising’ and ‘including’ will be understood to imply the inclusion of a stated integer or group of integers but not the exclusion of any other integer or group of integers.
This application is a continuation of U.S. application Ser. No. 13/740,662, filed Jan. 14, 2013, now U.S. Pat. No. 9,724,217, which is a continuation application of U.S. application Ser. No. 12/454,797 filed May 22, 2009, now U.S. Pat. No. 8,361,134, which is a divisional application of U.S. application Ser. No. 10/818,538, filed Apr. 5, 2004, now U.S. Pat. No. 7,537,606 which application in turn claims priority to provisional application Ser. No. 60/510,244, filed Oct. 10, 2003 and Ser. No. 60/460,291, filed Apr. 3, 2003, which are incorporated herein in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
5387235 | Chuter | Feb 1995 | A |
5425765 | Tiefenbrun et al. | Jun 1995 | A |
5445646 | Euteneuer et al. | Aug 1995 | A |
5617878 | Taheri | Apr 1997 | A |
5628783 | Quiachon et al. | May 1997 | A |
5683449 | Marcade | Nov 1997 | A |
5720776 | Chuter et al. | Feb 1998 | A |
5749920 | Quiachon et al. | May 1998 | A |
5769885 | Quiachon et al. | Jun 1998 | A |
5968069 | Dusbabek et al. | Oct 1999 | A |
5984955 | Wisselink | Nov 1999 | A |
6015429 | Lau et al. | Jan 2000 | A |
6030414 | Taheri | Feb 2000 | A |
6099558 | White et al. | Aug 2000 | A |
6129738 | Lashinski | Oct 2000 | A |
6136006 | Johnson et al. | Oct 2000 | A |
6156063 | Douglas | Dec 2000 | A |
6206931 | Cook et al. | Mar 2001 | B1 |
6235051 | Murphy | May 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6302891 | Nadal | Oct 2001 | B1 |
6331188 | Lau et al. | Dec 2001 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6428565 | Wisselink | Aug 2002 | B1 |
6514285 | Pinchasik | Feb 2003 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6596020 | Vardi et al. | Jul 2003 | B2 |
6613072 | Lau et al. | Sep 2003 | B2 |
6645242 | Quinn | Nov 2003 | B1 |
6652567 | Deaton | Nov 2003 | B1 |
6682536 | Vardi et al. | Jan 2004 | B2 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6723116 | Taheri | Apr 2004 | B2 |
6770092 | Richter | Aug 2004 | B2 |
6875229 | Wilson et al. | Apr 2005 | B2 |
6939370 | Hartley et al. | Sep 2005 | B2 |
7131991 | Zarins et al. | Nov 2006 | B2 |
7238198 | Hartley et al. | Jul 2007 | B2 |
7435253 | Hartley et al. | Oct 2008 | B1 |
8545549 | Hartley et al. | Oct 2013 | B2 |
20010016767 | Wilson | Aug 2001 | A1 |
20010037142 | Stelter et al. | Nov 2001 | A1 |
20020040236 | Lau et al. | Apr 2002 | A1 |
20020072790 | McGuckin et al. | Jun 2002 | A1 |
20020091439 | Baker et al. | Jul 2002 | A1 |
20020138088 | Nash et al. | Sep 2002 | A1 |
20020143383 | Parodi | Oct 2002 | A1 |
20020156523 | Lau et al. | Oct 2002 | A1 |
20020169497 | Wholey | Nov 2002 | A1 |
20020183763 | Callol et al. | Dec 2002 | A1 |
20020198585 | Wisselink | Dec 2002 | A1 |
20030069561 | Choi | Apr 2003 | A1 |
20030114911 | Lupton | Jun 2003 | A1 |
20030120332 | Hartley | Jun 2003 | A1 |
20030135257 | Taheri | Jul 2003 | A1 |
20030199967 | Hartley et al. | Oct 2003 | A1 |
20030204242 | Zarins et al. | Oct 2003 | A1 |
20030208260 | Lau et al. | Nov 2003 | A1 |
20030225446 | Hartley | Dec 2003 | A1 |
20040082990 | Hartley | Apr 2004 | A1 |
20040111146 | McCullagh et al. | Jun 2004 | A1 |
Number | Date | Country |
---|---|---|
0684022 | Nov 1995 | EP |
1157674 | Nov 2001 | EP |
WO 9709007 | Mar 1997 | WO |
WO 9745073 | Dec 1997 | WO |
WO 9819628 | May 1998 | WO |
WO 9853761 | Dec 1998 | WO |
WO 9913808 | Mar 1999 | WO |
WO 9936002 | Jul 1999 | WO |
WO 0167993 | Sep 2001 | WO |
WO 02076346 | Oct 2002 | WO |
WO 03034948 | May 2003 | WO |
WO 03053287 | Jul 2003 | WO |
WO 03082153 | Oct 2003 | WO |
WO 2004002365 | Jan 2004 | WO |
WO 2004017867 | Mar 2004 | WO |
WO 2004017868 | Mar 2004 | WO |
Entry |
---|
Office Action for corresponding Canadian Application No. 2,518,890, dated Oct. 5, 2010, 3 pages. |
Notice of Allowance for corresponding Canadian Application No. 2,518,890, dated Aug. 22, 2011, 1 page. |
European Search Report for corresponding EP 09156931 dated Apr. 28, 2009, 3 pages. |
Examination Report for corresponding EP 04749755.7 dated Sep. 24, 2007, 3 pages. |
Examination Report for corresponding EP 04749755.7 dated Jul. 14, 2009, 3 pages. |
Office Action and English translation for corresponding Japanese Application No. 2006-509707, dated Nov. 6, 2009, 5 pages. |
International Search Report and Written Opinion for PCT/US2004/010445, dated Oct. 5, 2004, 12 pages. |
International Preliminary Report on Patentability for PCT/US2004/010445, dated Oct. 14, 2005, 8 pages. |
Jae Hyung Park, et al., Fenestrated Stent-Grafts for Preserving Visceral Arterial Branches in the Treatment of Abdominal Aortic Aneurysms: Preliminary Experience, Journal of Vascular and Interventional Radiology, University College of Medicine, Seoul, Korea, p. 819 (1996) (5 pages). |
Non-Final Office Action for U.S. Appl. No. 10/818,538 dated Sep. 19, 2007 (15 pages). |
Final Office Action for U.S. Appl. No. 10/818,538 dated Jan. 17, 2008 (12 pages). |
Non-Final Office Action for U.S. Appl. No. 10/818,538 dated Jun. 5, 2008 (9 pages). |
Final Office Action for U.S. Appl. No. 10/818,538 dated Nov. 25, 2008 (9 pages). |
Notice of Allowance for U.S. Appl. No. 10/818,538 dated Mar. 6, 2009 (6 pages). |
Non-Final Office Action for U.S. Appl. No. 12/454,797 dated Jul. 20, 2011 (11 pages). |
Final Office Action for U.S. Appl. No. 12/454,797 dated Jan. 31, 2012 (15 pages). |
Notice of Allowance for U.S. Appl. No. 12/454,797 dated Sep. 19, 2012 (8 pages). |
Non-Final Office Action for U.S. Appl. No. 13/740,662 dated Jan. 15, 2014 (16 pages). |
Final Office Action for U.S. Appl. No. 13/740,662 dated May 14, 2014 (17 pages). |
Non-Final Office Action for U.S. Appl. No. 13/740,662 dated Dec. 1, 2015 (17 pages). |
Final Office Action for U.S. Appl. No. 13/740,662 dated Sep. 7, 2016 (13 pages). |
Notice of Allowance for U.S. Appl. No. 13/740,662 dated Apr. 6, 2017(13 pages). |
Number | Date | Country | |
---|---|---|---|
20170333235 A1 | Nov 2017 | US |
Number | Date | Country | |
---|---|---|---|
60510244 | Oct 2003 | US | |
60460291 | Apr 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10818538 | Apr 2004 | US |
Child | 12454797 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13740662 | Jan 2013 | US |
Child | 15670782 | US | |
Parent | 12454797 | May 2009 | US |
Child | 13740662 | US |